Enara Bio raised €29M in a Series B round in Oct 2024. The company is based in Oxford, UK. Investors in the round: Francis Crick Institute, M Ventures, Pfizer. Data as of 7 Aug 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
This is the company's only recorded round.
